Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4132 |  RNTX Rein Therapeutics, Inc. - Common Stock | 0.78 USD | -4.88% | 0.00% | -2.50% | -29.09% | 67.29 M USD | ||
| 4136 |  XBIT XBiotech Inc. - Common Stock | 2.29 USD | -0.43% | -0.87% | +0.88% | -28.88% | 69.82 M USD | ||
| 4143 |  CSBR Champions Oncology, Inc. - Common Stock | 5.14 USD | +3.63% | +1.78% | -15.74% | -29.01% | 71.41 M USD | ||
| 4144 |  MNOV MediciNova, Inc. - Common Stock | 1.47 USD | +5.00% | +12.21% | +13.08% | +9.70% | 72.36 M USD | ||
| 4152 |  CRDF Cardiff Oncology, Inc. - Common Stock | 1.01 USD | +14.77% | +8.60% | +20.24% | -56.47% | 78.57 M USD | ||
| 4153 |  BOLD Boundless Bio, Inc. - Common Stock | 2.94 USD | -2.00% | +2.80% | +14.40% | +153.45% | 66.88 M USD | ||
| 4165 |  HYFT MindWalk Holdings Corp. - Common Stock | 1.40 USD | -0.71% | 0.00% | 0.00% | -30.69% | 65.40 M USD | ||
| 4169 |  TENX Tenax Therapeutics, Inc. - Common Stock | 1.73 USD | -1.14% | -5.98% | -88.27% | -77.09% | 64.74 M USD | ||
| 4176 |  INMB INmune Bio Inc. - Common stock | 2.30 USD | -0.86% | +8.49% | +41.10% | -3.36% | 63.83 M USD | ||
| 4187 |  DOMH Dominari Holdings Inc. - Common Stock | 2.55 USD | -1.16% | -1.16% | -4.49% | -60.65% | 61.82 M USD | ||
| 4188 |  IMA ImageneBio, Inc. - Common Stock | 5.70 USD | +3.45% | -2.56% | +0.53% | -60.25% | 64.70 M USD | ||
| 4190 |  INKT MiNK Therapeutics, Inc. - Common Stock | 11.91 USD | -2.38% | +5.03% | +7.01% | +8.27% | 60.78 M USD | ||
| 4197 |  HRTX Heron Therapeutics, Inc. - Common Stock | 0.31 USD | -3.12% | -8.82% | -34.04% | -77.86% | 58.85 M USD | ||
| 4203 |  RNXT RenovoRx, Inc. - Common Stock | 1.33 USD | +0.76% | -6.34% | +47.78% | +41.49% | 60.02 M USD | ||
| 4217 |  IMMP Immutep Limited - American Depositary Shares | 0.38 USD | -2.56% | 0.00% | 0.00% | -78.16% | 55.49 M USD | ||
| 4220 |  NTRB Nutriband Inc. - Common Stock | 4.76 USD | +1.93% | +48.29% | +58.67% | -32.96% | 57.86 M USD | ||
| 4242 |  APLM Apollomics Inc. - Class A Ordinary Shares | 24.33 USD | +3.22% | +2.23% | +34.64% | +293.05% | 53.43 M USD | ||
| 4243 |  XLO Xilio Therapeutics, Inc. - Common Stock | 9.32 USD | +0.98% | +1.19% | +7.75% | +1231.43% | 53.89 M USD | ||
| 4255 |  TIL Instil Bio, Inc. - Common Stock | 7.62 USD | +2.56% | +2.97% | +6.72% | -60.90% | 51.68 M USD | ||
| 4270 |  TCRX TScan Therapeutics, Inc. - Common Stock | 0.77 USD | -1.28% | 0.00% | -4.94% | -59.47% | 48.90 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |